Literature DB >> 29450811

Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery.

Neil Forster1, Ronald Warnick2, Vinita Takiar1, Luke Pater1, John Breneman3.   

Abstract

In patients with pituitary adenomas (PA) who are unable to undergo complete surgical resection, radiation therapy (RT), specifically stereotactic radiosurgery (SRS), results in excellent local control. However, the utility of radiosurgery may be limited by the proximity of the lesion to the optic chiasm (OC). We evaluate the efficacy of debulking surgery in increasing the PA-OC separation to convert patients into SRS candidates. From 2007 to 2015, 31 patients with PA < 2 mm from the OC underwent debulking surgery followed by RT within 2 years of resection. Coronal and sagittal T1-pre- and post-contrast sequences were used to determine PA-OC separation. Time interval between postoperative and pre-radiotherapy MRI scans and type of radiation therapy were analyzed. Functional tumor status, tumor characteristics [cavernous sinus (CS) or suprasellar (SS) involvement, chiasm/nerve encasement (NE)], and presence of ≥ 2 of these characteristics (multiple factors, MF) was also noted. Surgery converted 9 of 31 patients (29%) to SRS candidates. Median time from surgery to pre-RT planning MRI was 8 months (range 2-20). Of the 31 patients initially ineligible for SRS, 6 became eligible immediately after surgery, and another 3 were deemed eligible on follow-up. Mean PA-OC separation was 0.3 mm preoperative, 1.4 mm postoperative, and 2.1 mm at time of SRS (p = 0.002). Preoperative SS, NE, and MF involvement predicted pre-RT separation < 2 mm. Debulking surgery of unresectable pituitary tumors is a successful strategy for converting select radiosurgery-ineligible patients to radiosurgery candidates. Absence of preoperative SS, NE, and MF predicts for successful conversion.

Entities:  

Keywords:  Debulking surgery; Optic chiasm; Pituitary adenoma; Radiosurgery

Mesh:

Year:  2018        PMID: 29450811     DOI: 10.1007/s11060-018-2801-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy.

Authors:  C Alameda; T Lucas; E Pineda; M Brito; J G Uría; R Magallón; J Estrada; B Barceló
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

2.  Editorial: separation surgery.

Authors:  Charles Fisher; Juliet Batke
Journal:  J Neurosurg Spine       Date:  2013-01-22

3.  Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study.

Authors:  I Jonathan Pomeraniec; Robert F Dallapiazza; Zhiyuan Xu; John A Jane; Jason P Sheehan
Journal:  J Neurosurg       Date:  2015-10-30       Impact factor: 5.115

Review 4.  Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium.

Authors:  Jason P Sheehan; Ajay Niranjan; Jonas M Sheehan; John A Jane; Edward R Laws; Douglas Kondziolka; John Flickinger; Alex M Landolt; Jay S Loeffler; L Dade Lunsford
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

5.  Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.

Authors:  M Necmettin Pamir; Türker Kiliç; Muhittin Belirgen; Ufuk Abacioğlu; Nural Karabekiroğlu
Journal:  Neurosurgery       Date:  2007-08       Impact factor: 4.654

6.  Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.

Authors:  Y Greenman; G Ouaknine; I Veshchev; I I Reider-Groswasser; Y Segev; N Stern
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

7.  Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas.

Authors:  M Mitsumori; D C Shrieve; E Alexander; U B Kaiser; G E Richardson; P M Black; J S Loeffler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-10-01       Impact factor: 7.038

8.  Long-term results of stereotactic radiosurgery in secretory pituitary adenomas.

Authors:  Frederic Castinetti; Mariko Nagai; Isabelle Morange; Henry Dufour; Philippe Caron; Philippe Chanson; Christine Cortet-Rudelli; Jean-Marc Kuhn; Bernard Conte-Devolx; Jean Regis; Thierry Brue
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

9.  External radiotherapy of pituitary adenomas.

Authors:  D Zierhut; M Flentje; J Adolph; J Erdmann; F Raue; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-09-30       Impact factor: 7.038

10.  The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas.

Authors:  Paul Park; William F Chandler; Ariel L Barkan; John J Orrego; John A Cowan; Kent A Griffith; Christina Tsien
Journal:  Neurosurgery       Date:  2004-07       Impact factor: 4.654

View more
  1 in total

Review 1.  Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review.

Authors:  Odelia Cooper; Vivien Bonert; Ning-Ai Liu; Adam N Mamelak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-15       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.